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To the Editor:  Mycobacterium 
fortuitum complex members are rap-
idly growing mycobacteria found in 
water and soil (1). These opportunistic 
pathogens are responsible for posttrau-
matic skin and soft tissue infections. 
They also account for 60%–80% of 
postsurgical wound infections caused 
by rapidly growing mycobacteria (2), 
particularly after breast surgery (with 
or without prosthetic implants) (3). M. 
conceptionense, an emerging member 
of the M. fortuitum complex, was ini-
tially described in a case of osteomy-
elitis that occurred after an open frac-
ture of the tibia (4). We report a case 
of  M. conceptionense infection that 
occurred after breast surgery.
A woman 58 years of age had a 
left mastectomy with lymph node dis-
section and chemotherapy for breast 
carcinoma in March 2004. Three years 
later, she underwent breast reconstruc-
tion that used a cutaneomuscular 
latissimus dorsi ﬂ  ap with a prosthetic 
implant. Immediately after surgery, a 
fever (39°C) developed, but 3 blood 
cultures remained sterile. No treat-
ment was administered, and she be-
came afebrile within 3 days.
At day 15 after surgery, a serous 
discharge appeared in the tip of the 
skin ﬂ  ap. By day 21, the patient was 
again febrile, and the wound discharge 
was swabbed for analysis. On day 27, 
she underwent surgical revision with 
ablation of the breast implant, drain-
age, and sample collection. The leuko-
cyte count was normal. However, the 
C-reactive protein level was 99 mg/L, 
and the erythrocyte sedimentation rate 
was 111 mm (ﬁ  rst hour). Treatment 
with intravenous amoxicillin/clavu-
lanic acid was started. Although the 
biologic parameters normalized, the 
serous discharge continued. Micro-
scopic examination of specimens from   
days 21 and 27 yielded no bacteria in 
Gram- and Ziehl-Nielsen–stained pus 
specimens, and standard bacteriologic 
cultures remained sterile. M. concep-
tionense, identiﬁ   ed by partial rpoB 
gene sequencing (100% identity with 
GenBank accession no. AY859695.1) 
(4), grew in both specimens after 8 
days of incubation at 37°C under a 5% 
CO2 atmosphere in Coletsos medium 
(bioMérieux, La Balme-les-Grottes, 
France). By the Etest method (4), both 
isolates were susceptible to several an-
timicrobial drugs, including clarithro-
mycin, amikacin, ciproﬂ  oxacin,  and 
doxycycline. The patient was treated 
with ciproﬂ  oxacin, azythromycin, and 
amikacin for 3 weeks, followed by 
ciproﬂ  oxacin and azythromycin for 4 
weeks.
At patient’s relapse 3 months 
later,  M. conceptionense exhibiting 
identical antimicrobial drug suscepti-
bility pattern was again isolated from 
the wound ﬂ  uid. The patient was then 
treated with ciproﬂ  oxacin,  azythro-
mycin, and doxycycline for 6 months; 
subsequently, doxycycline alone was 
given for a total of 18 months. Results 
from the 2-month follow-up examina-
tion were unremarkable.
M. conceptionense was unambig-
uously identiﬁ  ed by partial rpoB gene 
sequencing, a ﬁ  rst-line tool for accurate 
identiﬁ  cation of nontuberculous myco-
bacteria (5). A pathogenic role for M. 
conceptionense was supported by 1) 
its repetitive isolation from the wound; 
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Table. Three cases of Mycobacterium conceptionense infection in female patients* 
Patient
age, y  Clinical situation  Identification
Treatment 
Reference  Nature Duration, mo
31 Posttraumatic osteitis  16S rRNA, soda, hsp65,
recA, rpoB†
Antimicrobial drug therapy: AMC  3 (4)
43 Subcutaneous abscess 
without trauma 
partial 1,464-bp 16S rRNA 
gene‡ 
Surgery and antimicrobial drug  
therapy: COT and CLA; then DOX and 
CLA; then LIN and CLA 
5( 10)
58 Breast implant infection  rpoB§  Surgery and antimicrobial drug  
therapy: CIP and AZY; then CIP, AZY, 
and DOX; then DOX 
18 This report 
*AMC, amoxicillin/clavulanic acid; COT, cotrimoxazole; CLA, clarithromycin; DOX, doxycycline; LIN, linezolid; CIP, ciprofloxacin, AZY, azythromycin. The 
outcome for all 3 patients was favorable.  
†GenBank accession nos.: 16S rRNA, AY859684; rpoB, AY859695; hsp65, AY859678; sodA, AY859708; recA, AY859690. 
‡GenBank accession no. AM884289.1. 
§GenBank accession no. AY859695.1. LETTERS
2) the absence of any other pathogen; 
and 3) wound healing during appropri-
ate, long-term antimicrobial drug treat-
ment. However, the source of infection 
remained unknown. The patient had 
a tattoo on the skin ﬂ  ap used for the 
breast reconstruction, and ink has been 
shown to be a source for rapidly grow-
ing mycobacteria other than M. con-
ceptionense ( 6). However, the tattoo 
was 5 years old and clinically safe.
Recent reports have identiﬁ  ed 12 
M. conceptionense isolates from wa-
ter collected in a cooling tower (7) 
and 9 isolates from various freshwater 
ﬁ  sh species (8). The type strain of M. 
conceptionense had been isolated af-
ter prolonged exposure of the patient 
to fresh water (4). These observations 
suggest that water is a potential source 
for M. conceptionense. In this patient, 
use of contaminated aqueous solutions 
or inadequately rinsed surgical equip-
ment (9) was unlikely the source of in-
fection because further investigations 
indicated proper use of sterilized, non-
reusable surgical equipment. At home, 
the patient used well water, but results 
of tests used to detect M. conception-
ense by culture and the presence of 
the rpoB gene in well water remained 
negative.
Because M. conceptionense is an 
emerging pathogen with only 2 re-
ported cases of infection (4,10), the 
optimal treatment is unknown (Table). 
Current recommendations for breast 
implant infection from M. fortuitum 
include 6 months of appropriate anti-
microbial drug treatment in addition to 
implant removal because surgery alone 
yields relapse within 4–6 weeks (2,3). 
Increased worldwide use of breast im-
plants is likely to increase the number 
of  M. conceptionense infections and 
will raise questions about the optimal 
management of these infections. 
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Rapid Diagnostic 
Tests and Severity 
of Illness in 
Pandemic (H1N1) 
2009, Taiwan 
To the Editor: The recent pan-
demic (H1N1) 2009 (1) demonstrates 
the need for more sensitive rapid di-
agnostic tests (RDTs) to distinguish 
between inﬂ  uenza and other respira-
tory viruses, enhance inﬂ  uenza  sur-
veillance, and institute early antiviral 
therapy for patients who are severely 
ill or at high risk (2). In anticipation of 
the global spread of pandemic (H1N1) 
2009, on August 15, 2009, the gov-
ernment of Taiwan began perform-
ing RDTs at clinics and hospitals for 
patients with inﬂ  uenza-like  illness. 
This initiative was based in part on the 
notion that patients with higher viral 
loads would be more likely to have a 
positive RDT result and more severe 
disease. We report that RDTs may 
have paradoxically lower sensitiv-
ity for pandemic (H1N1) 2009 virus 
for patients with respiratory failure 
requiring mechanical ventilation, ex-
tracorporeal membrane oxygenation 
(ECMO) or both than for those with-
out respiratory failure.
National Taiwan University Hos-
pital is a 2,200-bed teaching hospi-
tal in Taiwan. This hospital provides 
primary and tertiary care and ECMO. 
All patients admitted with presumed 
severe inﬂ   uenza were immediately 
treated with oseltamivir during the 
2009 pandemic. From July 25 through 
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